Beckman Coulter Genomic

Tuesday, 01 September, 2009

Beckman Coulter has created Beckman Coulter Genomic, a new company which combines Agencourt Bioscience and the newly acquired Cogenics, to offer researchers a single genomic services resource with expanded global capabilities.

“Through the creation of Beckman Coulter Genomics, we have successfully brought together the industry’s leading genomic service providers to offer our customers the highest quality data and analysis,” said Richard Creager PhD, Beckman Coulter group vice president of Immunoassay, Molecular Diagnostics and Genomic Services.

Genomic researchers dedicate months to collecting DNA and RNA samples. Before turning over precious samples for analysis, they need to be able to trust that their service provider understands the research goals and will deliver a successful outcome. From classic to cutting edge, Beckman Coulter Genomics’ team has expertise and experience on a wide range of genomic technology platforms and is dedicated to delivering the highest quality results. Services currently available through Beckman Coulter Genomics include sequencing, sample preparation, genotyping, gene expression, biological efficiency and safety testing, with support for all levels of regulatory compliance, including Clinical Laboratory Improvement Amendments (CLIA). In addition, Beckman Coulter Genomics offers all three commercially available next-generation sequencing platforms: Roche 454 Genome Sequencer FLX with Titanium, Applied Biosystems SOLiD and Illumina Genome Analyzer.

“We understand that each customer, each sample and each study is unique and extremely important,” said Susan Evans PhD, general manager of Beckman Coulter Genomics. “That is why we strive to create a partnership with each customer through a consistent and personalised approach. Our experienced team has the energy and resolve needed to deliver high-quality results scientists can trust, on time and on budget.”

Beckman Coulter Genomics has offices throughout North America and Europe. For more information about Beckman Coulter Genomics and its services please visit www.BeckmanGenomics.com, www.agencourt.com and www.cogenics.com.

Related News

Global competition targets 'undruggable' cancer protein

A new global competition offering over US$500,000 in prizes aims to spur drug discovery...

SMi Systems appoints Dr Ankur Mutreja as Senior Advisor

Mutreja was previously Head of Global South Partnerships at CEPI, where he was responsible for...

STA announces new Superstars of STEM, next President

Science & Technology Australia (STA) has announced the country's next Superstars of STEM,...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd